Richard Close
Stock Analyst at Canaccord Genuity
(2.27)
# 2,644
Out of 4,761 analysts
132
Total ratings
41.58%
Success rate
-2.01%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintains: Hold | $60 → $71 | $72.37 | -1.89% | 9 | Feb 7, 2025 | |
| PINC Premier | Maintains: Hold | $21 → $19 | $18.61 | +2.10% | 12 | Feb 5, 2025 | |
| EVH Evolent Health | Maintains: Buy | $23 → $16 | $10.43 | +53.40% | 11 | Jan 23, 2025 | |
| HCAT Health Catalyst | Maintains: Buy | $11 → $10 | $5.23 | +91.20% | 7 | Jan 21, 2025 | |
| ACCD Accolade | Downgrades: Hold | n/a | $6.93 | - | 9 | Jan 8, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $36 → $42 | $42.21 | -0.50% | 3 | Jan 3, 2025 | |
| PGNY Progyny | Maintains: Hold | $18 → $17 | $23.20 | -26.72% | 5 | Nov 13, 2024 | |
| AHCO AdaptHealth | Maintains: Buy | $14 → $13 | $8.45 | +53.85% | 6 | Nov 6, 2024 | |
| HSTM HealthStream | Maintains: Hold | $28 → $29 | $32.88 | -11.80% | 5 | Oct 23, 2024 | |
| PHR Phreesia | Maintains: Buy | $34 | $28.22 | +20.48% | 8 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $2.54 | +136.22% | 3 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $17 | $11.51 | +47.70% | 15 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $121.91 | -0.75% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $26 | $24.52 | +6.04% | 7 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $4.79 | +4.38% | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $4.40 | -31.82% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1,170 → $225 | $1.59 | +14,033.17% | 6 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $32.00 | -25.00% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $66.00 | +43.94% | 9 | Apr 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $19 → $18 | $49.06 | -63.82% | 4 | Dec 20, 2018 |
Doximity
Feb 7, 2025
Maintains: Hold
Price Target: $60 → $71
Current: $72.37
Upside: -1.89%
Premier
Feb 5, 2025
Maintains: Hold
Price Target: $21 → $19
Current: $18.61
Upside: +2.10%
Evolent Health
Jan 23, 2025
Maintains: Buy
Price Target: $23 → $16
Current: $10.43
Upside: +53.40%
Health Catalyst
Jan 21, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $5.23
Upside: +91.20%
Accolade
Jan 8, 2025
Downgrades: Hold
Price Target: n/a
Current: $6.93
Upside: -
Waystar Holding
Jan 3, 2025
Maintains: Buy
Price Target: $36 → $42
Current: $42.21
Upside: -0.50%
Progyny
Nov 13, 2024
Maintains: Hold
Price Target: $18 → $17
Current: $23.20
Upside: -26.72%
AdaptHealth
Nov 6, 2024
Maintains: Buy
Price Target: $14 → $13
Current: $8.45
Upside: +53.85%
HealthStream
Oct 23, 2024
Maintains: Hold
Price Target: $28 → $29
Current: $32.88
Upside: -11.80%
Phreesia
Sep 5, 2024
Maintains: Buy
Price Target: $34
Current: $28.22
Upside: +20.48%
Aug 16, 2024
Maintains: Buy
Price Target: $8 → $6
Current: $2.54
Upside: +136.22%
Aug 1, 2024
Maintains: Buy
Price Target: $25 → $17
Current: $11.51
Upside: +47.70%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $121.91
Upside: -0.75%
May 10, 2024
Maintains: Buy
Price Target: $37 → $26
Current: $24.52
Upside: +6.04%
May 9, 2024
Maintains: Buy
Price Target: $9 → $5
Current: $4.79
Upside: +4.38%
Mar 6, 2023
Maintains: Buy
Price Target: $4 → $3
Current: $4.40
Upside: -31.82%
Mar 9, 2022
Maintains: Hold
Price Target: $1,170 → $225
Current: $1.59
Upside: +14,033.17%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $32.00
Upside: -25.00%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $66.00
Upside: +43.94%
Dec 20, 2018
Downgrades: Hold
Price Target: $19 → $18
Current: $49.06
Upside: -63.82%